Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Obesity
- Polycystic Ovary Syndrome
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Masking Description: The study is open label. No blindness for participant or investigator is usedPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 38 years
- Gender
- Only males
Description
Polycystic Ovary Syndrome (PCOS)
Polycystic Ovary Syndrome (PCOS)
Tracking Information
- NCT #
- NCT02521753
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mardia Guadalupe López Alarcón, MD, phD Instituto Mexicano del Seguro Social